16 results
Diffuse large B cell lymphoma (DLBCL) - Management and Treatment Algorithm

By Matthew Ho, MD PhD @MatthewHoMD

#Diffuse
Diffuse large B cell lymphoma ... (DLBCL) - Management ... #DLBCL #Management ... Treatment #Algorithm #oncology ... #hematology
Treatment Approach to Hodgkin's Lymphoma

By Matthew Ho, MD PhD @MatthewHoMD
With Credit: Dr Sunita Nasta and Dr
Approach to Hodgkin's Lymphoma ... #Hodgkins #Lymphoma ... #oncology #Hematology ... #management #treatment
Causes of Localized Lymphadenopathy - Differential Diagnosis Algorithm
Cervical:
 - Anterior
     • Infection
•TB • Lymphoma ... : • Thoracic Malignancy ... Forearm/Hand) • Lymphoma ... Algorithm #Causes #Hematology ... #Oncology
Hodgkin's Lymphoma Overview

Hodgkin's lymphoma (HL) is an uncommon hematological malignancy arising from mature B cells. It
Hodgkin's Lymphoma ... hematological malignancy ... Workup: • Full ... classification #hematology ... #oncology #management
Approach to Thrombocytosis - Elevated Platelet Count - Differential Diagnosis Algorithm

Peripheral Smear concerning for malignancy?
concerning for malignancy ... → Refer to hematology ... for workup, including ... treatment • Malignancy ... Metastatic cancer, Lymphoma
Hodgkin's Lymphoma vs Non-Hodgkin's Lymphoma - Comparison

Hodgkin's Lymphoma:
 • Epidemiology: young adults 20-30, older 50-70
 •
Hodgkin's Lymphoma ... Non-Hodgkin's Lymphoma ... older 50-70 • Malignant ... NonHodgkins #comparison #oncology ... #differential #hematology
Tumor Lysis Syndrome
An acute, life-threatening condition that appears within 7 days of starting cytotoxic therapies in
chemosensitive malignancy ... like Burkitt's lymphoma ... Walid Malki, MD, MS ... Syndrome #TLS #oncology ... #management #UricAcid
Chronic Lymphocytic Leukemia - Summary

Cancer affecting lymphocytes/Mature B cell neoplasm
 • Lymphocytes accumulate in large numbers
the non-Hodgkin lymphoma ... Marginal zone lymphoma ... • Mantle cell lymphoma ... Leukemia #diagnosis #workup ... #oncology #hematology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
#DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
algorithm for VTE in Malignancy ... #DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology